Analysts Set Adient plc (NYSE:ADNT) PT at $18.22

Adient plc (NYSE:ADNTGet Free Report) has received a consensus rating of “Reduce” from the ten analysts that are presently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell recommendation and seven have given a hold recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $18.22.

ADNT has been the topic of a number of research reports. UBS Group raised their target price on shares of Adient from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday, May 8th. Citigroup began coverage on shares of Adient in a report on Wednesday, April 23rd. They issued a “neutral” rating and a $14.00 price target on the stock. Bank of America cut shares of Adient from a “neutral” rating to an “underperform” rating and lowered their price target for the company from $24.00 to $18.00 in a report on Tuesday, March 4th. Barclays cut shares of Adient from an “equal weight” rating to a “negative” rating in a report on Tuesday, April 15th. Finally, Wells Fargo & Company raised their price target on shares of Adient from $14.00 to $17.00 and gave the company an “equal weight” rating in a report on Monday, May 19th.

Read Our Latest Stock Report on Adient

Institutional Trading of Adient

Several institutional investors and hedge funds have recently bought and sold shares of the business. Covestor Ltd lifted its stake in Adient by 10.6% during the 4th quarter. Covestor Ltd now owns 6,062 shares of the company’s stock valued at $104,000 after acquiring an additional 580 shares during the period. Mariner LLC lifted its stake in Adient by 8.6% during the 4th quarter. Mariner LLC now owns 10,157 shares of the company’s stock valued at $175,000 after acquiring an additional 801 shares during the period. GAMMA Investing LLC lifted its stake in Adient by 157.5% during the 1st quarter. GAMMA Investing LLC now owns 2,235 shares of the company’s stock valued at $29,000 after acquiring an additional 1,367 shares during the period. Point72 Hong Kong Ltd acquired a new stake in Adient during the 4th quarter valued at approximately $25,000. Finally, Oarsman Capital Inc. lifted its stake in Adient by 98.7% during the 4th quarter. Oarsman Capital Inc. now owns 2,966 shares of the company’s stock valued at $51,000 after acquiring an additional 1,473 shares during the period. 92.44% of the stock is currently owned by institutional investors and hedge funds.

Adient Trading Up 6.8%

ADNT stock opened at $18.81 on Friday. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.08 and a quick ratio of 0.86. The company has a market capitalization of $1.58 billion, a PE ratio of 940.55, a P/E/G ratio of 0.34 and a beta of 1.64. The firm’s 50-day moving average is $13.71 and its 200 day moving average is $15.65. Adient has a 12 month low of $10.04 and a 12 month high of $28.46.

Adient (NYSE:ADNTGet Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.33. The business had revenue of $3.61 billion for the quarter, compared to the consensus estimate of $3.39 billion. Adient had a negative net margin of 0.01% and a positive return on equity of 6.94%. The company’s revenue for the quarter was down 3.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.54 EPS. On average, research analysts anticipate that Adient will post 1.76 EPS for the current year.

About Adient

(Get Free Report

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.

Further Reading

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.